ulcerative colitis and semaglutide Patients with stable inflammatory bowel disease (IBD) comorbid obesity and/or diabetes who started GLP-1 receptor agonists (semaglutide or tirzepatide) alongside ongoing treatment did not have a lower risk for the relapse GLP-1 receptor agonists in IBD:
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22












:max_bytes(150000):strip_icc()/GettyImages-2269148459-808f11c37f9547848f6a60f511f26238.jpg)











